New Mexico Register / Volume
XXXI, Issue 11 / June 9, 2020
This is an amendment
to 13.10.13 NMAC, Section 12, effective July 1, 2020.
13.10.13.12 COST SHARING:
A. All cost sharing (including copayments, deductibles, co-insurance, or similar charges) required of covered persons by the health care insurer or managed health care plan for the provision of health care services shall be reasonable and shall include any applicable state and federal taxes.
B. Any
cost sharing requirement for the provision of testing and delivery of health
care services for COVID-19 (including testing/screening for pneumonia and
influenza, treatment for pneumonia when due to or a result of COVID-19
infection, and treatment for influenza when a co-infection with COVID-19) or
any disease or condition which is the cause of, or subject of, a public health
emergency is presumptively unreasonable and is prohibited. For purpose of this rule, a public health
emergency exists when declared by the state of New Mexico or
federal government [, or by order of the superintendent].
C. Cost sharing requirements, including any variations in contribution requirements based on the type of health care service rendered or provider used, shall be disclosed to covered persons in MHCP contracts, enrollment materials, and in the evidence of coverage.
D. No female covered person shall be assessed a higher cost sharing requirement, over and above the cost sharing required of all covered persons to be seen by a primary care physician, for choosing a women’s health care provider as her primary care physician
E. Health care services for any disease or condition for which cost sharing is prohibited under Paragraph B of this section shall be subject to the Surprise Billing Protection Act, Sections 59A-57A-1 through 13, NMSA 1978 (the “Act”). Where there is no data available in the Act’s benchmarking databases for a particular billing code, then the health care insurer or managed health care plan shall reimburse under the Act at one hundred fifty percent of the Medicare reimbursement rate applicable for the year in which the benchmarking data first becomes available.
[13.10.13.12 NMAC - Rp, 13.10.13.27 NMAC, 09/01/2009; A/E, 3/12/2020; A, 7/01/2020]